{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:53:36Z","timestamp":1780620816799,"version":"3.54.1"},"reference-count":300,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020247","name":"University of Bisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.prp.2023.154817","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:38:23Z","timestamp":1694633903000},"page":"154817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma"],"prefix":"10.1016","volume":"250","author":[{"given":"Mai A.","family":"Abd-Elmawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohada M.","family":"AL-Noshokaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen Saeid","family":"Elshaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"El-Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Midan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Mohammed El","family":"Tabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad Gamil","family":"Khidr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouda Kamel","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41588-023-01321-1","article-title":"Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity","volume":"55","author":"Mangiante","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2023.154817_bib2","series-title":"Thoracic tumours","author":"WCoTE","year":"2021"},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jtho.2017.04.002","article-title":"Epidemiology of environmental exposure and malignant mesothelioma","volume":"12","author":"Liu","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2023.154817_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.5915","article-title":"Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: a review of the National Cancer Database","author":"Bou\u2010Samra","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-023-06330-1","article-title":"ATG5 as biomarker for early detection of malignant mesothelioma","volume":"16","author":"Tomasetti","year":"2023","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.prp.2023.154817_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920971421","article-title":"Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma","volume":"12","author":"Yang","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2023.154817_bib8","article-title":"MicroRNAs as important regulators mediate the multiple differentiation of mesenchymal stromal cells","volume":"9","author":"Yang","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib9","first-page":"73","article-title":"MicroRNA-499 gene expression in egyptian type 2 diabetes mellitus patients with and without coronary heart disease","volume":"2","author":"Oraby","year":"2022","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.prp.2023.154817_bib10","article-title":"Association of miRNA-499 rs3746444 A> G genotype variants with type 2 diabetes mellitus and its coronary heart disease complication in adult Egyptian population","volume":"29","author":"Oraby","year":"2022","journal-title":"Gene Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib11","article-title":"MiR-216a in diabetic nephropathy: relation with autophagy and apoptosis","volume":"7","author":"Elshaer","year":"2018","journal-title":"Int. J. Pharm. Res. Allied Sci."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib12","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2022-0074","article-title":"The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke","volume":"8","author":"Salman","year":"2022","journal-title":"Future Sci. OA"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib13","first-page":"66","article-title":"The clinical value of circulating MicroRNAs in acute ischemic stroke","volume":"2","author":"Salman","year":"2022","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.prp.2023.154817_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","article-title":"A review of the biological role of miRNAs in prostate cancer suppression and progression","volume":"197","author":"Doghish","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154817_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijbiomac.2022.06.134","article-title":"miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: a spotlight on signaling pathways interplay\u2014a review","volume":"214","author":"Elrebehy","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154817_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153886","article-title":"miRNAs inspirations in hepatocellular carcinoma: detrimental and favorable aspects of key performers","author":"El-Mahdy","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120923","article-title":"Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: a review","author":"Elsakka","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154817_bib18","article-title":"Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review","author":"Ismail","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154817_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154222","article-title":"The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance-a focus on signaling pathways interplay","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance \u2013 a focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154053","article-title":"A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: a focus on signaling pathways interplay","author":"Doghish","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154316","article-title":"miRNAs role in bladder cancer pathogenesis and targeted therapy: signaling pathways interplay-a review","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib23","article-title":"miRNAs role in cervical cancer pathogenesis and targeted therapy: signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154371","article-title":"Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib25","article-title":"miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance\u2013an emphasis on the interaction of signaling pathways","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154411","article-title":"The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154424","article-title":"miRNAs as potential game-changers in melanoma: a comprehensive review","author":"Abd-Allah","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121667","article-title":"An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer","author":"Fathi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154817_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-a review","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib31","article-title":"A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154457","article-title":"miRNAs as potential game-changers in head and neck cancer: future clinical and medicinal uses","author":"El-Mahdy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121697","article-title":"Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats","volume":"323","author":"Allam","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154817_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105195","article-title":"Impact of the mother's gut microbiota on infant microbiome and brain development","author":"Mady","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.prp.2023.154817_bib36","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay","author":"Elshaer","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154557","article-title":"miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11","author":"Elrebehy","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib39","article-title":"miRNAs as potential game-changers in retinoblastoma: future clinical and medicinal uses","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154584","article-title":"The potential role of miRNAs in the pathogenesis of salivary gland cancer \u2013 a Focus on signaling pathways interplay","volume":"247","author":"Abulsoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154590","article-title":"miRNAs orchestration of salivary gland cancer- particular emphasis on diagnosis, progression, and drug resistance","author":"El-Husseiny","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib42","article-title":"The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154612","article-title":"miRNAs orchestration of testicular germ cell tumors - particular emphasis on diagnosis, progression and drug resistance","author":"Elesawy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154665","article-title":"miRNAs orchestration of adrenocortical carcinoma - particular emphasis on diagnosis, progression and drug resistance","author":"El-Dakroury","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib45","article-title":"The potential role of miRNAs in the pathogenesis of gallbladder cancer - a focus on signaling pathways interplay","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154684","article-title":"miRNAs orchestration of gallbladder cancer - particular emphasis on diagnosis, progression and drug resistance","author":"Shahin","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154690","article-title":"The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma \u2013 a focus on signaling pathways interplay","volume":"248","author":"Midan","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154763","article-title":"miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma","volume":"249","author":"Al-Noshokaty","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154771","article-title":"The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: signaling pathway crosstalk","author":"Rizk","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154375","article-title":"The role of miRNAs in liver diseases: potential therapeutic and clinical applications","volume":"243","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib51","article-title":"miRNAs as potential game-changers in bone diseases: future medicinal and clinical Uses","author":"Doghish","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154704","article-title":"miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma","volume":"248","author":"Elkady","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154715","article-title":"Decoding the role of miRNAs in multiple myeloma pathogenesis: a focus on signaling pathways","author":"Yehia","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154613","article-title":"miRNAs orchestration of cardiovascular diseases \u2013 particular emphasis on diagnosis, and progression","volume":"248","author":"Elsakka","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154624","article-title":"The potential role of miRNAs in the pathogenesis of cardiovascular diseases \u2013 a focus on signaling pathways interplay","volume":"248","author":"Khidr","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib56","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.sjbs.2021.02.001","article-title":"MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8","volume":"28","author":"Elkady","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.prp.2023.154817_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes, Metab. Syndr. Obes.: Targets Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib58","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as novel diagnostic biomarkers in adult egyptian male patients with metabolic syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.prp.2023.154817_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121321","article-title":"miRNAs insights into rheumatoid arthritis: favorable and detrimental aspects of key performers","volume":"314","author":"Doghish","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154817_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154512","article-title":"Long non-coding RNAs and rheumatoid arthritis: pathogenesis and clinical implications","author":"Elazazy","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.106978","article-title":"miRNAs as cornerstones in diabetic microvascular complications","volume":"138","author":"Ismail","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.prp.2023.154817_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123189","article-title":"The role of miRNAs in insulin resistance and diabetic macrovascular complications \u2013 a review","volume":"230","author":"Abdel Mageed","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154817_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121382","article-title":"miRNAs as cornerstones in adipogenesis and obesity","volume":"315","author":"Elkhawaga","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib64","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.dsx.2018.11.058","article-title":"Plasma endoglin in Type2 diabetic patients with nephropathy","volume":"13","author":"Doghish","year":"2019","journal-title":"Diabetes Metabolic Syndrome Clin. Res. Rev."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib65","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/cbin.11653","article-title":"miRNAs; a novel strategy for the treatment of COVID\u201019","volume":"45","author":"Ying","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.prp.2023.154817_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271271","article-title":"Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at fayoum university hospital in Egypt","volume":"17","author":"Ismail","year":"2022","journal-title":"Plos One"},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249346","article-title":"Clinical characteristics of Egyptian male patients with COVID\u201019 acute respiratory distress syndrome","volume":"16","author":"Doghish","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.prp.2023.154817_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112681","article-title":"MicroRNAs in Alzheimer's disease: potential diagnostic markers and therapeutic targets","volume":"148","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/ddr.22064","article-title":"Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease","volume":"84","author":"Eissa","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.prp.2023.154817_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00445","article-title":"Circulating epigenetic biomarkers in malignant pleural mesothelioma: state of the art and critical evaluation","volume":"10","author":"Ferrari","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib72","article-title":"Serum expression levels of certain miRNAs in predicting diagnosis, prognosis, and response to chemotherapy in malignant pleural mesothelioma","volume":"39","author":"Metinta\u015f","year":"2022","journal-title":"Balk. Med. J."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33116-z","article-title":"Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos","volume":"13","author":"Di Mauro","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000528670","article-title":"miR-142-3p suppresses invasion and adhesion of mesothelioma cells by downregulating ITGAV","volume":"90","author":"Endo","year":"2023","journal-title":"Pathobiology"},{"key":"10.1016\/j.prp.2023.154817_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.prp.2023.154817_bib76","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2023.154817_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond","author":"Abd El Fattah","year":"2022","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154817_bib78","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med"},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib79","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Res."},{"issue":"7014","key":"10.1016\/j.prp.2023.154817_bib80","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154817_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib82","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib83","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154817_bib84","series-title":"Regulation of microRNAs, miRNomics","first-page":"1","author":"Ergin","year":"2022"},{"issue":"7149","key":"10.1016\/j.prp.2023.154817_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.prp.2023.154817_bib86","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib87","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154817_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154567","article-title":"The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b\/ZEB1 axis","volume":"247","author":"Salman","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154570","article-title":"LncRNA NNT-AS1\/hsa-miR-485\u20135p\/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: a step toward ncRNA Precision","volume":"247","author":"El-Sheikh","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: a review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic significance of miR-639 and miR-10b in \u03b2reast cancer patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"issue":"7795","key":"10.1016\/j.prp.2023.154817_bib92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","article-title":"Loss of p53 drives neuron reprogramming in head and neck cancer","volume":"578","author":"Amit","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prp.2023.154817_bib93","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ng2079","article-title":"Target mimicry provides a new mechanism for regulation of microRNA activity","volume":"39","author":"Franco-Zorrilla","year":"2007","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.prp.2023.154817_bib94","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.prp.2023.154817_bib95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","article-title":"Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics","volume":"81","author":"Yang","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib96","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ccr.2007.10.028","article-title":"p53 enters the microRNA world","volume":"12","author":"Hermeking","year":"2007","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib97","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2023.154817_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.prp.2023.154817_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bj.2020.03.001","article-title":"The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness","volume":"43","author":"Wu","year":"2020","journal-title":"Biomed. J."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib101","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cells8060528","article-title":"Hypoxia- and MicroRNA-induced metabolic reprogramming of tumor-initiating cells","volume":"8","author":"Ullmann","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib102","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs dysregulation in human malignant pleural mesothelioma","volume":"6","author":"Balatti","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib103","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma\u2014a miRNA microarray analysis","volume":"48","author":"Guled","year":"2009","journal-title":"Genes, Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib104","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ram\u00edrez-Salazar","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"30","key":"10.1016\/j.prp.2023.154817_bib106","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5\u20136","key":"10.1016\/j.prp.2023.154817_bib107","first-page":"330","article-title":"miR-34a expression, cell cycle arrest and cell death of malignant mesothelioma cells upon treatment with radiation, docetaxel or combination treatment","volume":"81","author":"Ghawanmeh","year":"2012","journal-title":"Oncology"},{"issue":"15","key":"10.1016\/j.prp.2023.154817_bib108","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib109","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Khodayari","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2023.154817_bib111","first-page":"4481","article-title":"Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer","author":"Lee","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib112","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.7150\/ijbs.13453","article-title":"Blockage of epithelial to mesenchymal transition and upregulation of let 7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell","volume":"12","author":"Sohn","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib113","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial\u2013mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib114","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib115","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib116","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"issue":"46","key":"10.1016\/j.prp.2023.154817_bib117","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.prp.2023.154817_bib118","doi-asserted-by":"crossref","first-page":"36338","DOI":"10.18632\/oncotarget.8916","article-title":"MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma","volume":"7","author":"Tomasetti","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib119","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","article-title":"MicroRNA and cancer","volume":"6","author":"Jansson","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2023.154817_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00105","article-title":"Manipulating microRNAs for the treatment of malignant pleural mesothelioma: past, present and future","volume":"10","author":"Reid","year":"2020","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib122","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res."},{"issue":"46","key":"10.1016\/j.prp.2023.154817_bib123","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib124","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"issue":"27","key":"10.1016\/j.prp.2023.154817_bib125","doi-asserted-by":"crossref","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib126","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib127","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ram\u00edrez-Salazar","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib128","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/1541-7786.MCR-14-0442","article-title":"Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma","volume":"13","author":"Birnie","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib129","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10528-022-10186-8","article-title":"CircPLK1 acts as a carcinogenic driver to promote the development of malignant pleural mesothelioma by governing the miR-1294\/HMGA1 pathway","volume":"60","author":"Zhang","year":"2022","journal-title":"Biochem. Genet."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib130","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int J. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2023.154817_bib131","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","article-title":"MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis","volume":"27","author":"Singh","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib132","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcb.25609","article-title":"MicroRNA control of p53","volume":"118","author":"Liu","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"41","key":"10.1016\/j.prp.2023.154817_bib133","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.18632\/oncotarget.27010","article-title":"Transcriptional suppression of the miR-15\/16 family by c-Myc in malignant pleural mesothelioma","volume":"10","author":"Williams","year":"2019","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib134","first-page":"1193","article-title":"Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways","volume":"2","author":"Williams","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.prp.2023.154817_bib135","article-title":"A comparison between the effects of over-expression of miRNA-16 and miRNA-34a on cell cycle progression of mesothelioma cell lines and on their cisplatin sensitivity","volume":"26","author":"Pinelli","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib136","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.prp.2023.154817_bib138","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1089\/ars.2013.5215","article-title":"MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Tomasetti","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.prp.2023.154817_bib139","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.omtn.2021.04.001","article-title":"MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis","volume":"24","author":"Singh","year":"2021","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Khodayari","year":"2011","journal-title":"Cancer Gene Ther."},{"issue":"9","key":"10.1016\/j.prp.2023.154817_bib141","first-page":"1996","article-title":"MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells","volume":"6","author":"Khodayari","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib142","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"13","key":"10.1016\/j.prp.2023.154817_bib143","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or tumor suppressor? The duplicity of microRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154817_bib144","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fonc.2018.00446","article-title":"miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma","volume":"8","author":"Suzuki","year":"2018","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib145","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib146","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2020.03.172","article-title":"HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells","volume":"526","author":"Fujii","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hed.21713","article-title":"Exploiting salivary miR\u201031 as a clinical biomarker of oral squamous cell carcinoma","volume":"34","author":"Liu","year":"2012","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2023.154817_bib148","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12094-013-1014-4","article-title":"Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer","volume":"15","author":"Wang","year":"2013","journal-title":"Clin. Transl. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib149","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI39566","article-title":"MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors","volume":"120","author":"Liu","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2023.154817_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0303-2","article-title":"Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component","volume":"31","author":"Matsumoto","year":"2014","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib151","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33116-z","article-title":"Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos","volume":"13","author":"Di Mauro","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154817_bib152","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cncy.21869","article-title":"miR\u2010130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology","volume":"125","author":"Cappellesso","year":"2017","journal-title":"Cancer Cytopathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib153","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncy.21646","article-title":"Young investigator challenge: MicroRNA\u201021\/MicroRNA\u2010126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"124","author":"Cappellesso","year":"2016","journal-title":"Cancer Cytopathol."},{"issue":"50","key":"10.1016\/j.prp.2023.154817_bib154","doi-asserted-by":"crossref","first-page":"82700","DOI":"10.18632\/oncotarget.12408","article-title":"Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers","volume":"7","author":"Bononi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154817_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105700","article-title":"Mechanism of miR-222 and miR-126 regulation and its role in asbestos-induced malignancy","volume":"121","author":"Gaetani","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib156","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/jcb.27586","article-title":"Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa\u2010miR\u20102053 and lncRNA\u2010RP1\u201386D1. 3 axis expression in malignant pleural mesothelioma","volume":"120","author":"Matboli","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/srep06152","article-title":"Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma","volume":"4","author":"Hudson","year":"2014","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.prp.2023.154817_bib158","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154817_bib159","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","author":"Zhu","year":"2016","journal-title":"Drug Des., Dev. Ther."},{"key":"10.1016\/j.prp.2023.154817_bib160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lungcan.2018.03.022","article-title":"Loss of C\/EBP-\u03b2 LIP drives cisplatin resistance in malignant pleural mesothelioma","volume":"120","author":"Kopecka","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2023.154817_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.718675","article-title":"Upregulation of thymidylate synthase induces pemetrexed resistance in malignant pleural mesothelioma","volume":"12","author":"Sato","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib162","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1570-7458.2002.00982.x","article-title":"Costs of secondary parasitism in the facultative hyperparasitoid Pachycrepoideus dubius: does host size matter?","volume":"103","author":"Grandgirard","year":"2002","journal-title":"\u00c8ntomol. Exp. Et. Appl."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib163","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/15384047.2017.1415677","article-title":"Micro-RNA149 confers taxane resistance to malignant mesothelioma cells via regulation of P-glycoprotein expression","volume":"19","author":"Kenworthy","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib164","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/life12060897","article-title":"Multidrug resistance of cancer cells and the vital role of P-glycoprotein","volume":"12","author":"Karthika","year":"2022","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib166","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cmet.2006.08.009","article-title":"Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function","volume":"4","author":"Nose","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.prp.2023.154817_bib167","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semcancer.2021.05.023","article-title":"Interference between copper transport systems and platinum drugs","author":"Arnesano","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib168","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.109.063172","article-title":"Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs","volume":"77","author":"Howell","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib169","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5306\/wjco.v7.i1.106","article-title":"Role of copper transporters in platinum resistance","volume":"7","author":"Kilari","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154817_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1055356","article-title":"The copper transporter CTR1 and cisplatin accumulation at the single-cell level by LA-ICP-TOFMS","volume":"9","author":"Schoeberl","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-022-02597-9","article-title":"DNA repair and damage pathways in mesothelioma development and therapy","volume":"22","author":"Malakoti","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"16","key":"10.1016\/j.prp.2023.154817_bib172","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1074\/jbc.M111.225375","article-title":"Novel role of base excision repair in mediating cisplatin cytotoxicity","volume":"286","author":"Kothandapani","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2023.154817_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-259","article-title":"Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells","volume":"9","author":"Sabatino","year":"2010","journal-title":"Mol. Cancer"},{"issue":"23","key":"10.1016\/j.prp.2023.154817_bib174","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.3390\/ijms21239248","article-title":"Role of nucleotide excision repair in cisplatin resistance","volume":"21","author":"Duan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib175","first-page":"6336","article-title":"Overexpression of xeroderma pigmentosum group C decreases the chemotherapeutic sensitivity of colorectal carcinoma cells to cisplatin","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib176","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0215(20000920)89:5<453::AID-IJC9>3.0.CO;2-E","article-title":"ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells","volume":"89","author":"Britten","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6496-1","article-title":"Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours","volume":"20","author":"Cierna","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib178","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12885-019-5314-0","article-title":"Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro","volume":"19","author":"Borchert","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154817_bib179","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2015.10.003","article-title":"Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links","volume":"35","author":"Sawant","year":"2015","journal-title":"DNA Repair"},{"key":"10.1016\/j.prp.2023.154817_bib180","doi-asserted-by":"crossref","first-page":"e478s","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clinics"},{"key":"10.1016\/j.prp.2023.154817_bib181","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fonc.2018.00016","article-title":"Role of BRCA mutations in the modulation of response to platinum therapy","volume":"8","author":"Mylavarapu","year":"2018","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib182","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ijo.2013.2070","article-title":"p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax","volume":"43","author":"Kim","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib183","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/cancers12102757","article-title":"AXL inactivation inhibits mesothelioma growth and migration via regulation of p53 expression","volume":"12","author":"Song","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154817_bib184","series-title":"The Role p53 Protein in DNA Repair, p53-A Guardian of the Genome and Beyond","author":"Mary","year":"2021"},{"key":"10.1016\/j.prp.2023.154817_bib185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.08.011","article-title":"The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?","volume":"107","author":"Bronte","year":"2016","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib186","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and Pyrido [2, 3-D] pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154817_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154211","article-title":"Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase","volume":"240","author":"Ismail","year":"2022","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.prp.2023.154817_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"key":"10.1016\/j.prp.2023.154817_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136336","article-title":"New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story","volume":"1294","author":"Eissa","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib190","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.prp.2023.154817_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106729","article-title":"Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations","author":"Azmy","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"15","key":"10.1016\/j.prp.2023.154817_bib192","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3390\/molecules28155812","article-title":"Antimicrobial, antibiofilm, and anticancer activities of syzygium aromaticum essential oil nanoemulsion","volume":"28","author":"Shehabeldine","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2023.154817_bib193","article-title":"Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: synthesis, characterization, antimicrobial, and anticancer activities","volume":"77","author":"Doghish","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"46","key":"10.1016\/j.prp.2023.154817_bib194","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1039\/D1RA04345E","article-title":"Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer","volume":"11","author":"Doghish","year":"2021","journal-title":"RSC Adv."},{"issue":"16","key":"10.1016\/j.prp.2023.154817_bib195","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.3390\/polym14163352","article-title":"Synthesis of silver nanocomposite based on carboxymethyl cellulose: antibacterial, antifungal and anticancer activities","volume":"14","author":"Salem","year":"2022","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib196","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.prp.2023.154817_bib197","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/ph16081123","article-title":"Alvespimycin exhibits potential Anti-TGF-\u03b2 signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel approach","volume":"16","author":"Mohammed","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2023.154817_bib198","first-page":"8019","article-title":"The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non\u2011small cell lung cancer","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep. 17(6"},{"issue":"9","key":"10.1016\/j.prp.2023.154817_bib199","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/cells8091091","article-title":"Expression of fgfr1\u20134 in malignant pleural mesothelioma tissue and corresponding cell lines and its relationship to patient survival and fgfr inhibitor sensitivity","volume":"8","author":"Vlacic","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154817_bib200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2020.12.028","article-title":"Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival","volume":"153","author":"Chia","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2023.154817_bib201","doi-asserted-by":"crossref","DOI":"10.1111\/his.14916","article-title":"High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma","author":"Chu","year":"2023","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib202","first-page":"312","article-title":"Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?","volume":"3","author":"Pillai","year":"2013","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/14737140.2021.1856660","article-title":"The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma","volume":"21","author":"Arulananda","year":"2021","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.prp.2023.154817_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.apmt.2022.101560","article-title":"Smart\/stimuli-responsive hydrogels: State-of-the-art platforms for bone tissue engineering","author":"El-Husseiny","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.prp.2023.154817_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1174075","article-title":"Stimuli-responsive hydrogels: smart state of-the-art platforms for cardiac tissue engineering","volume":"11","author":"El-Husseiny","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.humpath.2006.12.013","article-title":"Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma","volume":"38","author":"Kleinberg","year":"2007","journal-title":"Hum. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib207","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/bjc.2014.220","article-title":"Multipoint targeting of the PI3K\/mTOR pathway in mesothelioma","volume":"110","author":"Zhou","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib208","doi-asserted-by":"crossref","DOI":"10.1038\/srep32992","article-title":"PI3 kinase pathway and MET inhibition is efficacious in malignant pleural mesothelioma","volume":"6","author":"Kanteti","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib209","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.3390\/ijms20102505","article-title":"ERK is a pivotal player of chemo-immune-resistance in cancer","volume":"20","author":"Salaroglio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib210","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01307-2","article-title":"MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib211","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11523-022-00900-2","article-title":"Molecular alterations in malignant pleural mesothelioma: A hope for effective treatment by targeting YAP","volume":"17","author":"Dubois","year":"2022","journal-title":"Target. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib212","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib213","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","article-title":"YAP\/TAZ signaling and resistance to cancer therapy","volume":"5","author":"Nguyen","year":"2019","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib214","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02744-4","article-title":"EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1","volume":"4","author":"Ando","year":"2021","journal-title":"Commun. Biol."},{"issue":"16","key":"10.1016\/j.prp.2023.154817_bib215","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"issue":"22","key":"10.1016\/j.prp.2023.154817_bib216","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.3390\/cancers13225664","article-title":"Mesothelioma malignancy and the microenvironment: molecular mechanisms","volume":"13","author":"Cersosimo","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib217","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S1556-0864(16)30318-5","article-title":"211P: Inflammatory cells characterization and localization in malignant pleural mesothelioma (MPM) tissue samples: correlation with histologic subtype and prognosis","volume":"11","author":"Pasello","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2023.154817_bib218","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12307-012-0100-4","article-title":"The role of regulatory T cells in mesothelioma","volume":"5","author":"Ireland","year":"2012","journal-title":"Cancer Microenviron."},{"issue":"8","key":"10.1016\/j.prp.2023.154817_bib219","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154817_bib220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","article-title":"Matrix metalloproteinase (MMP)-2\u20131306\u2009C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients","volume":"5","author":"Elkady","year":"2016","journal-title":"Gene Rep."},{"key":"10.1016\/j.prp.2023.154817_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.797900","article-title":"ECM Mechanoregulation In Malignant Pleural Mesothelioma","volume":"10","author":"Panzetta","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib222","first-page":"4879","article-title":"The role of angiogenesis in malignant pleural effusion: from basic research to clinical application","volume":"12","author":"Zhao","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib223","first-page":"55","article-title":"The role of interleukin-6 in malignant mesothelioma","volume":"4","author":"Rahim","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib224","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1183\/09031936.00146808","article-title":"Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis","volume":"35","author":"Montes-Worboys","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"24","key":"10.1016\/j.prp.2023.154817_bib225","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.3390\/cancers14246063","article-title":"Immune checkpoint inhibitors in malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"14","author":"Gemelli","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib226","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib227","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib228","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/molecules21070965","article-title":"Targeting epithelial\u2013mesenchymal transition (EMT) to overcome drug resistance in cancer","volume":"21","author":"Du","year":"2016","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.prp.2023.154817_bib229","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.3390\/ijms222212216","article-title":"The Epithelial-to-Mesenchymal transition (EMT) in the development and metastasis of malignant pleural mesothelioma","volume":"22","author":"Ramundo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib230","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211754","article-title":"Epithelial\u2013mesenchymal transition and its transcription factors","volume":"42","author":"Debnath","year":"2022","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.prp.2023.154817_bib231","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2183\/pjab.85.314","article-title":"Transforming growth factor-\u03b2 signaling in epithelial-mesenchymal transition and progression of cancer","volume":"85","author":"Miyazono","year":"2009","journal-title":"Proc. Jpn. Acad., Ser. B"},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib232","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-\u03b2 synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Fujii","year":"2012","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib233","first-page":"1193","article-title":"Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways","volume":"2","author":"Williams","year":"2019","journal-title":"Cancer Drug Resist."},{"issue":"19","key":"10.1016\/j.prp.2023.154817_bib234","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.3390\/cancers14194784","article-title":"Exploring MicroRNA and exosome involvement in malignant pleural mesothelioma drug response","volume":"14","author":"Johnson","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154817_bib235","first-page":"1","article-title":"MicroRNAs as potential biomarkers in malignant pleural mesothelioma","author":"Santoni-Rugiu","year":"2015","journal-title":"Curr. Biomark. Find."},{"issue":"7","key":"10.1016\/j.prp.2023.154817_bib236","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181270","article-title":"The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases","volume":"12","author":"Goto","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib237","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bcp.2008.06.007","article-title":"Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1\/P-glycoprotein expression in human cancer cells","volume":"76","author":"Zhu","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-30-20","article-title":"Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)","volume":"30","author":"Bian","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib239","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1016\/j.cellsig.2013.08.032","article-title":"MiR-27a modulates the MDR1\/P-glycoprotein expression by inhibiting FZD7\/\u03b2-catenin pathway in hepatocellular carcinoma cells","volume":"25","author":"Chen","year":"2013","journal-title":"Cell. Signal."},{"issue":"41","key":"10.1016\/j.prp.2023.154817_bib240","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.18632\/oncotarget.27010","article-title":"Transcriptional suppression of the miR-15\/16 family by c-Myc in malignant pleural mesothelioma","volume":"10","author":"Williams","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154817_bib241","article-title":"A comparison between the effects of over-expression of miRNA-16 and miRNA-34a on cell cycle progression of mesothelioma cell lines and on their cisplatin sensitivity","volume":"26","author":"Pinelli","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"issue":"39","key":"10.1016\/j.prp.2023.154817_bib242","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2023.154817_bib243","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s12032-009-9344-3","article-title":"Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells","volume":"27","author":"Yang","year":"2010","journal-title":"Med. Oncol."},{"issue":"16","key":"10.1016\/j.prp.2023.154817_bib244","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1093\/nar\/gkn522","article-title":"miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes","volume":"36","author":"Liu","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib245","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.483","article-title":"miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress","volume":"4","author":"Lezina","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2023.154817_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110903","article-title":"miR-1: a comprehensive review of its role in normal development and diverse disorders","volume":"132","author":"Safa","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154817_bib247","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.2147\/OTT.S191247","article-title":"miR-125a-5p inhibits colorectal cancer cell epithelial\u2013mesenchymal transition, invasion and migration by targeting TAZ","volume":"12","author":"Tang","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib248","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma","volume":"16","author":"Andersen","year":"2014","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib249","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2010.10.006","article-title":"Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells","volume":"300","author":"Akao","year":"2011","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib250","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/genes13050875","article-title":"Analysis of miR-143, miR-1, miR-210 and let-7e Expression In Colorectal Cancer In Relation To Histopathological Features","volume":"13","author":"Romanowicz","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.prp.2023.154817_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00650","article-title":"MicroRNAs for the diagnosis and management of malignant pleural mesothelioma: a literature review","volume":"8","author":"Lo Russo","year":"2018","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib252","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/CBM-160319","article-title":"MicroRNA in breast cancer: the association with BRCA1\/2","volume":"19","author":"Petrovic","year":"2017","journal-title":"Cancer Biomark."},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib253","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41419-020-03192-4","article-title":"Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms","volume":"11","author":"Ferrari","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib254","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3892\/or.2014.3481","article-title":"MiR-379\/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma","volume":"32","author":"Yamamoto","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2023.154817_bib255","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fbioe.2020.00913","article-title":"MicroRNA-126 modulates palmitate-induced migration in HUVECs by downregulating myosin light chain kinase via the ERK\/MAPK pathway","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.prp.2023.154817_bib256","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2010121308","article-title":"TGF-\u03b2\/Smad3 signaling promotes renal fibrosis by inhibiting miR-29","volume":"22","author":"Qin","year":"2011","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"issue":"22","key":"10.1016\/j.prp.2023.154817_bib257","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.prp.2023.154817_bib258","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1073\/pnas.1008301107","article-title":"miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor","volume":"107","author":"Renthal","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib259","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/15384101.2017.1395533","article-title":"SOX9\/miR-130a\/CTR1 axis modulates DDP-resistance of cervical cancer cell","volume":"17","author":"Feng","year":"2018","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.prp.2023.154817_bib260","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/cells11091509","article-title":"MicroRNA-145 impairs classical non-homologous end-joining in response to ionizing radiation-induced DNA double-strand breaks via targeting DNA-PKcs","volume":"11","author":"Sudhanva","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2023.154817_bib261","first-page":"1","article-title":"P53 sensitizes breast cancer stem cells to let-7 miRNAs induced repression","volume":"1","author":"Xin","year":"2014","journal-title":"Int. J. Cancer Clin. Res"},{"issue":"24","key":"10.1016\/j.prp.2023.154817_bib262","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1080\/15384101.2020.1857958","article-title":"MiR-17-5p promotes the endothelialization of endothelial progenitor cells to facilitate the vascular repair of aneurysm by regulating PTEN-mediated PI3K\/AKT\/VEGFA pathway","volume":"19","author":"Tian","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2023.154817_bib263","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.omtn.2017.07.001","article-title":"MicroRNA-31 regulates chemosensitivity in malignant pleural mesothelioma","volume":"8","author":"Moody","year":"2017","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib264","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48133-0","article-title":"Exosomal miR-16-5p as a target for malignant mesothelioma","volume":"9","author":"Munson","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib265","first-page":"1031","article-title":"MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets","volume":"7","author":"Reid","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.prp.2023.154817_bib266","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopha.2016.03.007","article-title":"miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer","volume":"80","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4801-z","article-title":"MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses","volume":"18","author":"Tomasetti","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2023.154817_bib268","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2019.08.001","article-title":"Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: role of miR-126 in cancer-stroma communication","volume":"463","author":"Monaco","year":"2019","journal-title":"Cancer Lett."},{"issue":"28","key":"10.1016\/j.prp.2023.154817_bib269","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/onc.2013.335","article-title":"Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer","volume":"33","author":"Huang","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib270","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","volume":"9","author":"Catalano","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.prp.2023.154817_bib271","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014479","article-title":"The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis","volume":"296","author":"Mashimo","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2023.154817_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101400","article-title":"Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killing","volume":"20","author":"Monaco","year":"2022","journal-title":"Transl. Oncol."},{"issue":"17","key":"10.1016\/j.prp.2023.154817_bib273","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"issue":"25","key":"10.1016\/j.prp.2023.154817_bib274","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.18632\/oncotarget.24644","article-title":"MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma","volume":"9","author":"Nicol\u00e8","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154817_bib275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-med-041316-085813","article-title":"New concepts in the treatment of malignant pleural mesothelioma","volume":"69","author":"Wald","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"10","key":"10.1016\/j.prp.2023.154817_bib276","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/cancers12102767","article-title":"Non-invasive biomarkers for early detection of breast cancer","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib277","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncy.21342","article-title":"The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi\u2010institution survey","volume":"121","author":"Paintal","year":"2013","journal-title":"Cancer Cytopathol."},{"issue":"32","key":"10.1016\/j.prp.2023.154817_bib278","doi-asserted-by":"crossref","first-page":"53751","DOI":"10.18632\/oncotarget.17910","article-title":"Biomarkers for early diagnosis of malignant mesothelioma: do we need another moonshot?","volume":"8","author":"Lagniau","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib279","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/ijms19020595","article-title":"Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma","volume":"19","author":"Mart\u00ednez-Rivera","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154817_bib280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018232","article-title":"Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma","volume":"6","author":"Santarelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2023.154817_bib281","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/635748","article-title":"MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion","volume":"2015","author":"Ak","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib282","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arbr.2014.03.012","article-title":"Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses","volume":"50","author":"Porcel","year":"2014","journal-title":"Arch. De. Bronconeumol. (Engl. Ed. )"},{"key":"10.1016\/j.prp.2023.154817_bib283","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8628612","article-title":"MicroRNA signatures in malignant pleural mesothelioma effusions","volume":"2019","author":"Birnie","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2023.154817_bib284","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2017.08.003","article-title":"The biology, function and clinical implications of exosomes in lung cancer","volume":"407","author":"Zhou","year":"2017","journal-title":"Cancer Lett."},{"issue":"7\u20138","key":"10.1016\/j.prp.2023.154817_bib285","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2012.02.009","article-title":"Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients","volume":"45","author":"Tomasetti","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.prp.2023.154817_bib286","first-page":"740","article-title":"Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"13","author":"Gayosso-G\u00f3mez","year":"2014","journal-title":"EXCLI J."},{"key":"10.1016\/j.prp.2023.154817_bib287","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9280170","article-title":"Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma","volume":"2017","author":"Weber","year":"2017","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib288","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176680","article-title":"Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease","volume":"12","author":"Cavalleri","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib289","first-page":"2198","article-title":"Selection of microRNAs in extracellular vesicles for diagnosis of malignant pleural mesothelioma by in vitro analysis","volume":"44","author":"Jotatsu","year":"2020","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154817_bib290","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/cancers15010125","article-title":"Serum extracellular vesicle-derived microRNAs as potential biomarkers for pleural mesothelioma in a European prospective study","volume":"15","author":"Casalone","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.prp.2023.154817_bib291","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c*is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib292","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-014-0303-2","article-title":"Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component","volume":"31","author":"Matsumoto","year":"2014","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib293","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.prp.2023.154817_bib294","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11111205","article-title":"Diagnostic and prognostic value of three microRNAs in environmental asbestiform fibers-associated malignant mesothelioma","volume":"11","author":"Filetti","year":"2021","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154817_bib295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ramirez-Salazar","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2023.154817_bib296","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-017-2133-z","article-title":"miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma","volume":"470","author":"Mairinger","year":"2017","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.154817_bib297","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9645940","article-title":"MicroRNA expression in malignant pleural mesothelioma and asbestosis: a pilot study","volume":"2017","author":"Mozzoni","year":"2017","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.prp.2023.154817_bib298","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2023.154817_bib299","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"De Santi","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.prp.2023.154817_bib300","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1878-0261.12386","article-title":"Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma","volume":"12","author":"He","year":"2018","journal-title":"Mol. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823005174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823005174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:02:55Z","timestamp":1759734175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823005174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":300,"alternative-id":["S0344033823005174"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154817","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154817"}}